U.S. Wireless Telecom Stock News

Dyne Therapeutics recently advanced its neuromuscular pipeline, initiating the global Phase 3 HARMONIA trial of z-basivarsen for myotonic dystrophy type 1 and releasing new 24‑month data from the Phase 1/2 DELIVER trial of z-rostudirsen in Duchenne muscular dystrophy, alongside reporting a full-year 2025 net loss of US$446.21 million. With FDA alignment on HARMONIA’s confirmatory design, multiple regulatory designations for both assets, and additional long-term cardiopulmonary data in DMD,...

Lifecore Biomedical (LFCR) just posted its FY 2025 fourth quarter numbers, with revenue of US$36.4 million and a basic EPS loss of US$0.06. This sets the tone for a year where the trailing twelve months show revenue at about US$129.5 million and a basic EPS loss of US$0.92. Over recent quarters, revenue has moved from US$24.7 million in Q1 FY 2025 to US$31.1 million in Q3 and then US$36.4 million in Q4. Quarterly basic EPS losses ranged from US$0.53 in Q1 to US$0.29 in Q3 and US$0.06 in Q4,...

Why TriMas is on investors’ radar today TriMas (TRS) has drawn fresh interest as investors look at its recent share performance alongside its value score of 3 and current market capitalization of about US$1.32b. The stock shows a 1 day return of 1.23%, a month return decline of 2.21%, and a past 3 months return of 3.77%, while the 1 year total return stands at 42.54%. See our latest analysis for TriMas. The recent 1 day share price gain of 1.23% to US$35.47 comes after a weaker 7 day and year...

What Alibaba Group Holding (NYSE:BABA) offers investors right now Alibaba Group Holding (NYSE:BABA) gives you exposure to a broad ecosystem that spans e-commerce marketplaces, logistics, cloud computing, digital media, local services, healthcare, and collaboration tools across China and international markets. See our latest analysis for Alibaba Group Holding. Alibaba’s recent share price shows mixed momentum, with a 1 day share price return of 1.11% and a 7 day share price return of 3.07%,...

In March 2026, Amylyx Pharmaceuticals reported fourth-quarter and full-year 2025 results showing a reduced net loss of US$33.0 million for the quarter and US$144.74 million for the year, alongside narrower basic losses per share, and filed new shelf registrations covering common and preferred stock, debt, warrants, and units. An interesting angle is that Amylyx paired this improvement in reported losses with fresh shelf capacity, potentially increasing its flexibility to fund pipeline and...

Investors may be wondering if Credo Technology Group Holding at around US$116.88 is still offering value after such a strong run, or if enthusiasm has already been priced in. The stock has returned 0.8% over the last week, a 3.8% decline over 30 days, an 18.4% decline year to date and a 148.6% gain over the past year, with a very large 3 year return that is well over 10x. These moves have kept Credo on the radar for investors who focus on price momentum and shifts in sentiment. Recent...

AAR Manufacturing LLC, a unit of AAR Corp. (NYSE:AIR), has been awarded a long term contract with the U.S. Department of War. The agreement covers repair of the 463L Legacy Cargo Pallet system for the U.S. Air Force through 2031. The contract extends AAR’s government services work beyond its existing commercial-focused operations. For investors watching NYSE:AIR at a current share price of $105.64, this contract adds a fresh data point to an already strong share price run, with the stock up...

If you are wondering whether LTC Properties at around US$38.99 is offering good value today, it helps to step back and look at what the recent share performance and fundamentals are really telling you. The stock has delivered a 0.6% return over the last week, a 1.0% decline over the past month, and is up 12.5% year to date and 15.5% over the past year, with longer term returns of 41.0% over three years and 26.1% over five years. Recent attention on LTC Properties has focused on its position...

Consolidated Edison recently entered into a new US$3.50 billions revolving credit facility to support its commercial paper programs and general corporate purposes, shortly after reporting Q4 2025 revenue and adjusted EPS that topped Wall Street expectations. Together with management’s plans for a five-year adjusted EPS compound annual growth rate of 6% to 7%, the expanded credit access highlights how the utility is prioritizing both liquidity and earnings visibility. We’ll now look at how...

Broadcom (AVGO) is in focus after a series of AI related announcements, including reports of rapid growth in AI semiconductor revenue, the introduction of the new Taurus 400G optical DSP and Tomahawk 6 switches, and new work on open optical standards. See our latest analysis for Broadcom. Even with all the AI headlines, Broadcom’s recent share price performance has cooled, with a 7 day share price return of a 6.02% decline and a 90 day share price return of a 4.80% decline, while the 1 year...

KE Holdings (NYSE:BEKE) FY 2025 Results Overview KE Holdings (NYSE:BEKE) has wrapped up FY 2025 with fourth quarter revenue of C¥22.2b and basic EPS of C¥0.08, alongside trailing 12 month revenue of C¥94.6b and basic EPS of C¥2.70 that frame the latest print for investors watching the stock around C¥16.90 per share. The company has seen quarterly revenue range from C¥22.1b to C¥26.0b over the past year, with basic EPS moving between C¥0.08 and C¥1.16 across FY 2025. This gives a clearer view...

OPAL Fuels (OPAL) has capped FY 2025 with fourth quarter revenue of US$99.8 million and basic EPS of US$0.08, setting a clean reference point for how its earnings story is developing. Over the past year, the company has seen quarterly revenue range from US$80.0 million to US$99.8 million and basic EPS move from a small loss of US$0.01 in Q1 2025 to positive readings in each subsequent quarter, giving you a clearer view of how the income line is tracking into year end. With trailing net profit...

ServiceNow (NOW) is back in focus after rolling out several AI powered products and partnerships across government, telecom, healthcare, and security, giving investors fresh context for assessing the software group’s recent volatility. See our latest analysis for ServiceNow. Despite this steady stream of AI partnerships and product launches across government, telecom, and healthcare, ServiceNow’s 30 day share price return of 7.28% sits against a 90 day share price return decline of 26.46% and...

Event context and recent performance Ellington Financial (EFC) has recently drawn attention after a period where the stock showed a return of about 1.2% over the past week, compared with weaker moves over the month and past 3 months. See our latest analysis for Ellington Financial. At a share price of $11.94, Ellington Financial has seen short term momentum soften, with a 30 day share price return of a 7.7% decline and a year to date share price return of a 12.7% decline. However, the 3 year...

Earlier this month, AbbVie reported positive Phase 1 multiple-ascending-dose results for its investigational obesity drug ABBV-295, a long-acting amylin analog that induced clinically meaningful, dose-dependent weight loss with generally mild gastrointestinal side effects over 12–13 weeks of treatment. The data highlight AbbVie’s push into a mechanistically distinct class of obesity therapies beyond incretin-based drugs, adding another potential pillar to its already broad pipeline in...

Zepp Health (ZEPP) has wrapped up FY 2025 with fourth quarter revenue of US$85.2 million and a basic EPS loss of US$0.69, setting the tone for how you might read the full year at the current share price of US$16.22. The company has seen quarterly revenue move from US$59.5 million in Q4 2024 to US$85.2 million in Q4 2025, while basic EPS over that stretch has shifted from a loss of US$2.29 to a loss of US$0.69. This puts the focus squarely on how sustainably margins can tighten those losses...

Why DiDi Global’s latest earnings matter for shareholders DiDi Global (OTCPK:DIDI.Y) has released fourth quarter and full year 2025 results, with higher reported sales alongside a quarterly net loss and lower annual net income, giving you a mixed profitability picture to weigh. For the fourth quarter, DiDi Global reported sales of CNY 58,445 million compared with CNY 52,914 million a year earlier, and a net loss of CNY 338 million versus a CNY 1,341 million loss in the prior year...

Ross Stores (NasdaqGS:ROST) is opening 17 new locations across 11 U.S. states as part of its 2026 expansion plan. The openings mark the first phase of a targeted 110 new stores the company aims to add this fiscal year. Each grand opening includes charitable contributions to local youth organizations in the surrounding communities. Ross Stores operates off price retail banners that focus on discounted apparel and home goods, a segment that often attracts value oriented shoppers. The decision...

Zions Bancorporation National Association acted as lead arranger and bookrunner on Varex Imaging Corporation's new $490 million Credit and Guaranty Agreement. The bank will also serve as administrative and collateral agent for the syndicated credit facility. The transaction highlights Zions' role in complex corporate lending and syndicated loan coordination. Zions Bancorporation (NasdaqGS:ZION) is drawing attention for its role in a sizeable $490 million credit refinancing for Varex...

Vertiv Holdings Co (VRT) has been added to the S&P 500, following quarterly results where earnings and net sales beat expectations, guidance for 2026 was raised, and demand for its AI focused data center solutions featured prominently. See our latest analysis for Vertiv Holdings Co. Vertiv's recent S&P 500 inclusion and AI focused product and partnership announcements have come alongside strong momentum, with a 30 day share price return of 12.88% and a 1 year total shareholder return...

Recent performance snapshot for Accenture stock Accenture (ACN) has drawn investor attention after a period of weaker share performance, with the stock down about 11% over the past month and 27% over the past 3 months. Over the past year, Accenture's total return shows a 37% decline, while the year to date move sits at 23% lower, setting the context for how the current US$199.31 share price is being assessed. See our latest analysis for Accenture. Short term momentum has weakened, with a 7...

In March 2026, EXL launched an expanded suite of agentic AI solutions, upgrading its EXLerate.ai, EXLdecision.ai, EXLdata.ai and domain-specific workflow tools such as EXL ClaimsAssist.ai to help enterprises move from AI experimentation to large-scale, measurable impact. A distinct aspect of this rollout is EXL’s integrated ecosystem, combining data readiness, no-code autonomous agent building, decision intelligence and embedded workflow automation, which aims to make AI deployment more...

Investors may be wondering whether Equifax at around US$185 a share is starting to look interesting on price, or if it still feels expensive for what you get. The stock has seen a 9.5% decline over the last 7 days, a 4.0% decline over 30 days and is down 13.5% year to date and 22.2% over the last year, which naturally raises questions about whether expectations or risk perceptions have shifted. Recent headlines have focused on Equifax in the context of broader credit reporting and data...

Earlier in March 2026, ACADIA Pharmaceuticals received a formal negative opinion from the EMA’s CHMP on its marketing application for trofinetide in Rett syndrome, while also appointing biopharma finance executive Jonathan M. Poole to its Board and preparing a leadership presentation at the Longwood Healthcare Leaders Miami conference. This mix of regulatory setback in Europe and added financial expertise on the Board highlights a pivotal moment for ACADIA’s rare disease and CNS growth...